Felodipine NDC 23155-048

NDC codes

FDA NDC Directory

Product NDC (as listed)23155-048Labeler and product segments. Claims need a package NDC.

Product NDC at billing width23155-0048Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
23155-048-01	23155004801	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (23155-048-01)Marketed from Nov 8, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Felodipine
Generic name (nonproprietary): felodipine
Active ingredients: Felodipine — 2.5 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201964
Marketing start: Nov 8, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Calcium Channel Antagonists (Mechanism)Dihydropyridines (Chemical structure)
Identifiers: Product ID 23155-048_11a20aae-d449-4572-a9f3-f358d2da039fSPL ID 11a20aae-d449-4572-a9f3-f358d2da039fSPL set ID 0bef7cf2-012b-4804-ac93-0a8b333035dbRxCUI 402695, 402696, 402698UNII OL961R6O2CUPC 0323155049015, 0323155050011
Pharmacologic class: Dihydropyridine Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N423155004801 followed by a unit qualifier and the quantity

Package 23155-0048-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 11, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Felodipine extended-release tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to ac…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 201964

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201964
Product	Strength	Form · route	Labeler	Product NDC
Felodipine	Felodipine 5 mg/1	Tablet, Extended releaseOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-049
Felodipine	Felodipine 10 mg/1	Tablet, Extended releaseOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-050